Journal article icon

Journal article

Gene expression profiling in MDS and AML: potential and future avenues.

Abstract:

Today, the classification systems for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) already incorporate cytogenetic and molecular genetic aberrations in an attempt to better reflect disease biology. However, in many MDS/AML patients no genetic aberrations have been identified yet, and even within some cytogenetically well-defined subclasses there is considerable clinical heterogeneity. Recent advances in genomics technologies such as gene expression profiling (GEP) provide ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1038/leu.2011.48

Authors


Theilgaard-Mönch, K More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Clinical Lab Sciences, Biomedical Research Centre
Ferrari, S More by this author
Giannopoulos, K More by this author
Hernandez-Rivas, JM More by this author
Expand authors...
Journal:
Leukemia
Volume:
25
Issue:
6
Pages:
909-920
Publication date:
2011-06-05
DOI:
EISSN:
1476-5551
ISSN:
0887-6924
URN:
uuid:7a372fb4-65be-4fff-b520-b0637efeb270
Source identifiers:
246256
Local pid:
pubs:246256

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP